Abstract:Comprehensive Summary Valbenazine (Ingrezza), a potent and highly selective inhibitor of vesicular monoamine transporter type 2 (VMAT2) through the active metabolite hydrotetrabenazine (HTBZ), has been approved for the treatment of tardive dyskinesia and, very recently, for chorea, which is associated with Huntington's disease. Despite numerous synthetic efforts dedicated to the synthesis of HTBZ, the industrial preparation of valbenazine uses dihydroisoquinoline as a starting material and the chiral resolution of racemic HTBZ derived from ketone reduction. Herein, we present a practical synthesis of HTBZ and valbenazine featuring a highly stereoselective 1,3‐dipolar cycloaddition and enzymatic kinetic resolution. The cascade process includes cycloaddition, N˗O bond cleavage, and lactamization, which proved to be operationally simple. The allure of the enzymatic resolution developed in this work offers a rapid access toward affording tetrahydroisoquinoline (THIQ)‐fused piperidine to access key frameworks in the production of medically significant compounds, such as yohimbine and reserpine. This article is protected by copyright. All rights reserved.

Scale-Up Synthesis of Antidepressant Drug Vilazodone

Development of a Robust and Scalable Process for the Large-Scale Preparation of Vilazodone

Study on the Industryial Production of Citalopram

Diastereospecific epoxidation and highly regioselective ring-opening of (+)-valienamine: Practical synthesis of (+)-valiolamine

Synthesis of Antidepressant Drug Duloxetine Hydrochloride

Synthesis of antidepressant mirtazapine

A New and Practical Synthesis of Vortioxetine Hydrobromide

A Telescopic, Scalable and Industrially Feasible Method for the Synthesis of Antidepressant Drug, Moclobemide

[An Improved Novel Method of Venlafaxine Synthesis].

On Synthesis of Antidepressant Venlafaxine Hydrochloric Acidby Phase Transfer Catalysis

[Improved method of fluvoxamine synthesis].

An Improved Synthesis Method of Anti-depression Drug Duloxetine Hydrochloride

Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder

The Synthesis of (1-Oxaspiro[2.5]octan-2-ylmethoxy)(tert-butyl)dimethylsilane

Route Optimization on Selectivity and Kilogram-Scale Synthesis of Vilanterol Trifenatate

Process Development of a Novel Azetidinyl Ketolide Antibiotic

New production technology of vortioxetine hydrobromide

Synthesis of Donepezil Hydrochloride

Practical Synthesis of Valbenazine via 1,3‐Dipolar Cycloaddition

Synthesis of Fused Bicyclic [1,2,4]-Triazoles from Amino Acids

Enantioselective Synthesis Of S- And R-Fluoxetine Hydrochloride